This antibody reacts with human Chromogranin A in the neuroendocrine cells and neural tissues. It does not recognizes the epitopes located on the N-terminal half of the chromogranin A molecule. Cellular Localization: Cytoplasmic.
Cross-Reactivity (Details)
Species reactivity (tested):Human.
Purification
Purified
Immunogen
C-terminal half of chromogranin A was purified from urine of patients with carcinoid syndrome.
CHGA
Reactivity: Human
WB, ELISA
Host: Mouse
Monoclonal
1A6B6
unconjugated
Application Notes
Immunohistochemistry on Paraffin Embedded Sections: 1/20-1/50 in an ABC method(30-60 minutes at room temperature)Recommended Positive Control: Pancreas. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Format
Liquid
Buffer
10 mM Citrate buffer, pH 6.0 containing Sodium Azide as preservative.
Preservative
Sodium azide
Precaution of Use
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freezing and thawing.
Storage
4 °C/-20 °C
Storage Comment
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Chromogranin A (a protein of 439 amino acids which is encoded on chromosome 14) is present in neuroendocrine cells throughout the body, including the neuroendocrine cells of the large and small intestine, adrenal medulla and pancreatic islets. It is an excellent marker for carcinoid tumors, phenochromocytomas, paragangliomas, and other neuroendocrine tumors. Coexpression of chromogranin A and neuron specific enolase (NSE) is common in neuroendocrine neoplasms.Synonyms: CHGA, CgA, Chromogranin-A, Pituitary secretory protein I, SP-I